Unique Ingredient Identifier 2968PHW8QP is listed as a ingredient substance
| RN | 5949-29-1 |
| NCIT | C47452 |
| RXCUI | 221079 |
| PUBCHEM | 22230 |
| MF | C6H8O7.H2O |
| INCHI KEY | YASYEJJMZJALEJ-UHFFFAOYSA-N |
| SMILES | O.OC(=O)CC(O)(CC(O)=O)C(O)=O |
UNII 2968PHW8QP CITRIC ACID MONOHYDRATE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AN,CNBLK INTRATHECAL | INJECTION | 0.02 % |
| AN,INFILTRATION | INJECTION | 0.16 % |
| AURICULAR (OTIC) | SOLUTION | 1 % |
| AURICULAR (OTIC) | SOLUTION, DROPS | 0.04 % |
| BUCCAL | FILM, SOLUBLE | 0.69 MG |
| BUCCAL | TABLET | 30 MG |
| CAUDAL BLOCK | INJECTION | 20 % |
| EPIDURAL | INJECTION | 0.02 % |
| IM - IV | INJECTABLE | 0.05 % |
| IM - IV | INJECTION | 0.36 % |
| IM - IV | INJECTION | ADJ PH |
| IM - IV | SOLUTION | 0.05 % |
| IM - IV | SOLUTION, INJECTION | 0.088 % |
| IM - IV - SC | INJECTABLE | 0.2 % |
| IM - IV - SC | INJECTION | 1.26 % |
| IM - IV - SC | SOLUTION, INJECTION | 2.2 MG/1ML |
| IM - SC | INJECTION | 0.22 % |
| INFILTRATION | INJECTION | 0.02 % |
| INHALATION | AEROSOL, METERED | 0.002 MG/INH |
| INHALATION | INHALANT | NA |
| INHALATION | SOLUTION | 4.2 MG/1ML |
| INHALATION | SOLUTION | 4.04 MG/INH |
| INHALATION | SUSPENSION, FOR INHALATION | 0.028 % |
| INTRA-AMNIOTIC | INJECTION | 0.1 % |
| INTRA-ARTERIAL | SOLUTION, INJECTION | 0.05 % |
| INTRA-ARTICULAR | INJECTION | ADJPH |
| INTRA-ARTICULAR | INJECTION, SOLUTION | ADJ PH |
| INTRABURSAL | INJECTION | 0.21 % |
| INTRABURSAL | INJECTION | ADJPH |
| INTRACARDIAC | INJECTION | 2.5 mg/1mL |
| INTRACARDIAC | INJECTION | 1.05 % |
| INTRALESIONAL | INJECTION | ADJPH |
| INTRAMUSCULAR | INJECTABLE | 0.5 %W/V |
| INTRAMUSCULAR | INJECTION | 4.67 mg/1mL |
| INTRAMUSCULAR | INJECTION | 2 % |
| INTRAMUSCULAR | INJECTION | ADJPH |
| INTRAMUSCULAR | INJECTION, SOLUTION | 0.05 %W/V |
| INTRAMUSCULAR | INJECTION, SOLUTION | ADJ PH |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION | 0.03 % |
| INTRAMUSCULAR | SOLUTION, INJECTION | 0.02 % |
| INTRAMUSCULAR | SOLUTION, INJECTION | 0.02 %W/V |
| INTRAMUSCULAR | SUSPENSION, EXTENDED RELEASE | 0.75 % |
| INTRAMUSCULAR | SUSPENSION, INJECTION | 0.75 % |
| INTRAOCULAR | INJECTION, SOLUTION, CONCENTRATE | 0.025 % |
| INTRAOCULAR | SOLUTION | 0.05 % |
| INTRAPLEURAL | INJECTION | ADJPH |
| INTRAPLEURAL | POWDER, FOR INJECTION SOLUTION | 0.03 % |
| INTRASYNOVIAL | INJECTION | ADJPH |
| INTRATHECAL | INJECTION | ADJPH |
| INTRATHECAL | POWDER, FOR INJECTION SOLUTION | 0.03 % |
| INTRAVASCULAR | SOLUTION, INJECTION | 0.05 % |
| INTRAVENOUS | INJECTABLE | 38.46 % |
| INTRAVENOUS | INJECTABLE | 1.56 MG/1ML |
| INTRAVENOUS | INJECTION | 5.25 MG/1ML |
| INTRAVENOUS | INJECTION | 1 % |
| INTRAVENOUS | INJECTION | ADJ PH |
| INTRAVENOUS | INJECTION, SOLUTION | 0.4 MG/1ML |
| INTRAVENOUS | INJECTION, SOLUTION | 0.05 % |
| INTRAVENOUS | INJECTION, SOLUTION | ADJ PH |
| INTRAVENOUS | LIQUID | 0.2 % |
| INTRAVENOUS | LIQUID, CONCENTRATE, INJECTION | 0.053 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 50 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 384.6 mg |
| INTRAVENOUS | SOLUTION | 0.5 % |
| INTRAVENOUS | SOLUTION, CONCENTRATE | 0.003 % |
| INTRAVENOUS | SOLUTION, INJECTION | 5.25 MG/1ML |
| INTRAVENOUS | SOLUTION, INJECTION | 0.53 % |
| INTRAVENOUS INFUSION | INJECTION | 1 mg/1mL |
| IONTOPHORESIS | DRUG DELIVERY SYSTEM | 1.4 MG/PATCH |
| IONTOPHORESIS | PATCH, CONTROLLED RELEASE | 0.2 MG/PATCH |
| IONTOPHORESIS | SOLUTION | 0.02 % |
| IRRIGATION | INJECTION, SOLUTION, CONCENTRATE | 0.025 % |
| IV(INFUSION) | INJECTION | 1.05 % |
| IV(INFUSION) | LIQUID | 0.2 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | 6.92 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | ADJPH |
| IV(INFUSION) | SOLUTION, CONCENTRATE | ADJPH |
| IV(INFUSION) | SOLUTION, INJECTION | 0.38 % |
| NASAL | GEL | NA |
| NASAL | SOLUTION | 0.28 % |
| NASAL | SOLUTION, SPRAY, METERED, PUMP | 0.006 % |
| NASAL | SPRAY | 200 MCG/SPRAY |
| NASAL | SPRAY | 2.6 MG/INH |
| NASAL | SPRAY | 1.7 MG/1ML |
| NASAL | SPRAY | 0.044 % |
| NASAL | SPRAY, METERED | 35 MG/INH |
| NASAL | SPRAY, METERED | 0.42 % |
| NERVE BLOCK | INJECTION | 0.16 % |
| OPHTHALMIC | SOLUTION | 0.2 % |
| OPHTHALMIC | SOLUTION | 0.14 mg/1mL |
| OPHTHALMIC | SOLUTION, DROPS | 0.05 % |
| OPHTHALMIC | SUSPENSION | ADJPH |
| ORAL | BAR, CHEWABLE | 500 MG |
| ORAL | CAPSULE | 119 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 18.8 MG |
| ORAL | CAPSULE, SOFT GELATIN | 1 MG |
| ORAL | CAPSULE, SUSTAINED ACTION, HARD GELATIN | 18.8 MG |
| ORAL | CONCENTRATE | 7 MG/1ML |
| ORAL | DROPS | 1.8 MG/1ML |
| ORAL | EMULSION | NA |
| ORAL | FOR SUSPENSION | 5 MG/5ML |
| ORAL | GRANULE | 6.25 MG |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 4.9 MG |
| ORAL | GRANULE, FOR RECONSTITUTION | 6 MG |
| ORAL | GRANULE, FOR SUSPENSION | 14.1 MG/5ML |
| ORAL | GRANULE, FOR SUSPENSION | 9.1 MG |
| ORAL | LIQUID | 13.5 MG/1ML |
| ORAL | PELLET | 4.9 MG |
| ORAL | POWDER | 95 MG/1PKT |
| ORAL | POWDER | 95 MG/1SCP |
| ORAL | POWDER, FOR ORAL SOLUTION | 315 MG |
| ORAL | POWDER, FOR ORAL SOLUTION | 1.74 G/16 OZ |
| ORAL | POWDER, FOR ORAL SUSPENSION | 81 MG/1PKT |
| ORAL | POWDER, FOR ORAL SUSPENSION | 81 MG/1SCP |
| ORAL | POWDER, FOR RECONSTITUTION | 2.5 MG/5ML |
| ORAL | POWDER, FOR SOLUTION | 120 MG/PKT |
| ORAL | POWDER, FOR SUSPENSION | 140 MG/1ML |
| ORAL | SOLUTION | 53.1 mg |
| ORAL | SOLUTION | 24.85 MG/5ML |
| ORAL | SOLUTION | 7 MG/1ML |
| ORAL | SOLUTION | ADJPH |
| ORAL | SOLUTION, ELIXIR | 100 MG/5ML |
| ORAL | SOLUTION, LIQUID | 10 MG/1000ML |
| ORAL | SOLUTION, LIQUID | 7 MG/1ML |
| ORAL | SOLUTION, SYRUP | 22.15 MG |
| ORAL | SPRAY | 10.24 MG/1SPR |
| ORAL | SUSPENSION | 70.32 MG/5ML |
| ORAL | SUSPENSION | 5.14 mg/1mL |
| ORAL | SUSPENSION, DROPS | 6 MG/2.5ML |
| ORAL | SUSPENSION, FOR INHALATION | 0.612 MG/2ML |
| ORAL | SUSPENSION, LIQUID | 8.98 MG/1ML |
| ORAL | SUSPENSION, SUSTAINED ACTION | 140.8 MG/1PKT |
| ORAL | SUSPENSION, SUSTAINED ACTION | 5 MG/5ML |
| ORAL | SUSPENSION, SYRUP, SUSTAINED ACTION | 60 MG/5ML |
| ORAL | SYRUP | 60 MG/5ML |
| ORAL | TABLET | 78 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 2.56 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 4.26 MG |
| ORAL | TABLET, CHEWABLE | 1.2 MG |
| ORAL | TABLET, COATED | NA |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 1 MG |
| ORAL | TABLET, EXTENDED RELEASE | 24 MG |
| ORAL | TABLET, FILM COATED | 42 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 63 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 3.08 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 40 MG |
| ORAL | TABLET, UNCOATED, LOZENGE | 9.8 MG |
| ORAL | TABLET, UNCOATED, TROCHE | 12 MG |
| PARENTERAL | INJECTION | 0.05 % |
| PERIDURAL | INJECTION | NA |
| RECTAL | EMULSION, AEROSOL FOAM | 0.29 % |
| RESPIRATORY (INHALATION) | SUSPENSION, FOR INHALATION | 0.85 %W/V |
| SOFT TISSUE | INJECTION | ADJPH |
| SUBCUTANEOUS | INJECTION | 2.5 mg/1mL |
| SUBLINGUAL | TABLET | 12 MG |
| TOPICAL | AEROSOL | 0.11 %W/W |
| TOPICAL | AEROSOL, FOAM | 0.1 %W/W |
| TOPICAL | CREAM | 0.055 %W/W |
| TOPICAL | CREAM | 0.01 %W/W |
| TOPICAL | CREAM, AUGMENTED | 0.05 %W/W |
| TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 0.1 %W/W |
| TOPICAL | EMULSION | 0.11 %W/W |
| TOPICAL | EMULSION, AEROSOL FOAM | 0.11 %W/W |
| TOPICAL | EMULSION, CREAM | 0.44 %W/W |
| TOPICAL | EMULSION, CREAM | 0.18 %W/W |
| TOPICAL | EMULSION, LOTION | 0.05 %W/W |
| TOPICAL | GEL | 0.56 %W/W |
| TOPICAL | LIQUID | NA |
| TOPICAL | LOTION | 0.85 %W/W |
| TOPICAL | OINTMENT | 0.012 %W/W |
| TOPICAL | PATCH, CONTROLLED RELEASE | 0.2 MG/PATCH |
| TOPICAL | POWDER, FOR SOLUTION | NA |
| TOPICAL | SHAMPOO | 2.3 %W/W |
| TOPICAL | SHAMPOO | 0.24 %W/W |
| TOPICAL | SHAMPOO, SUSPENSION | 0.25 %W/V |
| TOPICAL | SOLUTION | 0.19 %W/W |
| TOPICAL | SOLUTION | 0.01 %V/V |
| TOPICAL | SOLUTION, DROPS | 0.014 %W/V |
| TOPICAL | SWAB | NA |
| TRANSDERMAL | DRUG DELIVERY SYSTEM | 1.4 MG/PATCH |
| TRANSDERMAL | FILM, EXTENDED RELEASE | 1.38 mg |
| VAGINAL | EMULSION, CREAM | 0.49 % |
| VAGINAL | SPONGE | 7.5 MG |